Hologic Downgraded by Barrington Research to Market Perform (HOLX)
Hologic (NASDAQ:HOLX) was downgraded by analysts at Barrington Research from an “outperform” rating to a “market perform” rating in a research report issued to clients and investors on Tuesday, TheFlyOnTheWall.com reports.
Hologic (NASDAQ:HOLX) traded down 0.77% during mid-day trading on Tuesday, hitting $25.66. The stock had a trading volume of 1,589,654 shares. Hologic has a one year low of $19.25 and a one year high of $26.75. The stock has a 50-day moving average of $25.51 and a 200-day moving average of $23.06. The company’s market cap is $7.127 billion.
Hologic (NASDAQ:HOLX) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.03. The company had revenue of $632.60 million for the quarter, compared to the consensus estimate of $621.89 million. During the same quarter in the previous year, the company posted $0.38 earnings per share. The company’s revenue for the quarter was up 1.0% on a year-over-year basis. Analysts expect that Hologic will post $1.45 EPS for the current fiscal year.
A number of other firms have also recently commented on HOLX. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Hologic in a research note on Thursday, July 31st. They now have a $31.00 price target on the stock, up previously from $28.00. Separately, analysts at SunTrust reiterated a “r” rating on shares of Hologic in a research note on Thursday, July 31st. They now have a $18.00 price target on the stock, up previously from $15.00. Finally, analysts at ISI Group raised their price target on shares of Hologic from $27.00 to $29.00 in a research note on Wednesday, July 9th. One investment analyst has rated the stock with a sell rating, twelve have assigned a hold rating and four have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $24.50.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.